Trial Profile
A Phase I Clinical Trial to Evaluate the Pharmacokinetics and Safety of MB12066 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Dec 2017
Price :
$35
*
At a glance
- Drugs Beta lapachone (Primary)
- Indications Macular degeneration; Metabolic syndrome; Non-alcoholic fatty liver disease
- Focus Adverse reactions
- Sponsors KT&G Life Sciences
- 31 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2015 New trial record